Oyster peptide inclusion compound as well as preparation method and application thereof

The resolvability and stability of the oyster peptide composition were solved by incorporating curcumin, puerar root extract and citrus extract with oyster peptides using methyl-β-cyclodextrin and hydroxypropyl-β-cyclodextrin. The problem of insufficient sexuality has achieved higher drug efficacy stability, antioxidant and anti-inflammatory effects, and extended the shelf life of the product.

CN118987157APending Publication Date: 2024-11-22THIRD INSTITUTE OF OCEANOGRAPHY STATE OCEANI C ADMINISTRATION
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411053009.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-02
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The resolvability and storage stability of existing oyster peptide compositions are insufficient, which affects its application effect in drugs and health products.

Method used

Using methyl-β-cyclodextrin and hydroxypropyl-β-cyclodextrin as inclusion materials, curcumin, pueraria root extract and citrus extract are integrated with oyster peptides to form oyster peptide inclusions. Optimize the mass ratio of the inclusion material to the total active ingredients to improve resolvency and stability.

Benefits of technology

It significantly reduces the hygroscopicity and storage stability of the inclusion compound, improves the drug effect stability, enhances the antioxidant, anti-inflammatory and hangover liver protection effects, and extends the shelf life of the product.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118987157A_ABST
    Figure CN118987157A_ABST
Patent Text Reader

Abstract

The invention provides an oyster peptide clathrate compound as well as a preparation method and application thereof, and belongs to the field of medicines, health-care products or foods. The oyster peptide clathrate comprises a total active component and a clathrate material, wherein the total active component comprises an active component A and oyster peptide; the active ingredient A is selected from at least one of curcumin, a radix puerariae extract and a hovenia dulcis thunb extract; the inclusion material is prepared from methyl-beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin. The oyster peptide clathrate is high in redissolution rate, low in hygroscopicity and good in storage stability, and has excellent effects of dispelling the effects of alcohol and protecting the liver.
Need to check novelty before this filing date? Find Prior Art